Page 3 - Biotech

Karnataka to unveil revised biotech policy: CM at Bengaluru Tech Summit

Karnataka Chief Minister Siddaramaiah on Wednesday said the government would unveil a revised biotech policy at the Bengaluru Tech Summit-2023, an annual global tech event which took off here. Speaking at the inauguration of the three-day BTS, Siddaramaiah also said the state is set to launch the Animation, Visual Effects, Gaming, Comics, and Extended Reality (AVGC-XR) policy. "As we continue to champion advancements in biotechnology, I am thrilled to announce that revised biotech policy is set to be unveiled at the Bangalore Tech Summit," the chief minister said. This policy revision reflects the Karnataka government's commitment to staying ahead of all and fostering growth in this critical sector, he added. Siddaramaiah said that recognising the evolving landscape technology and creativity, the Karnataka government understands the importance of animation, visual effects, gaming, and comics. "It gives me immense pleasure to share that the Government of Karnataka is set to launch

Pfizer enters talks to buy Seagen for over $30 billion, says report

Deal will help the firm add to its line-up of cancer treatments

Enzene Biosciences raises $50 million, aims to expand into global markets

Enzene said it has built a highly experienced 400-person team under the leadership of Dr. Himanshu Gadgil, CEO at Enzene Biosciences Ltd

Cough syrup deaths: Centre, UP team inspect pharma firm's Noida unit

Cough syrup maker linked to Uzbekistan deaths halts production; samples of Dok-1 Max sent for analysis

Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday

He was earlier the firm's deputy CEO; Outgoing MD Arun Chandavarkar to remain on co Board

World's most expensive drug approved to treat Hemophilia at $3.5 mn a dose

CSL Behring's Hemgenix, administered just once, cut the number of bleeding events expected over the course of a year by 54%, a key study of the therapy found

Biotech firm Bharat Serums & Vaccines working to reduce import dependence

Firm is develop recombinant products in hormones, eyes acquisitions in South East Asia

Mylab, firm that makes kits to detect Covid, starts pathology test facility

"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation

Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%

Biotechnology major Biocon on Wednesday reported a 71 per cent increase in consolidated net profit at Rs 144 crore for the June quarter on the back of robust growth across business verticals. The company had posted a net profit of Rs 84 crore in the April-June quarter of the previous fiscal. Total revenue rose to Rs 2,217 crore in the first quarter as compared with Rs 1,808 crore in the year-ago period, Biocon said in a regulatory filing. Biocon Executive Chairperson Kiran Mazumdar-Shaw said revenues grew as a result of robust growth in both biosimilar and generics verticals. "Our financial performance this quarter includes the impact of annual increments in personnel costs as well as increased input and freight costs, pursuant to pandemic and geopolitical disruptions of global supply chains," she added. All the company businesses are poised for the next phase of sustainable growth which has been challenged during the two years of the Covid pandemic, Mazumdar-Shaw said.

Silicon Valley's fallen superstar faces 20 years behind bars

Jurors found Holmes guilty of four counts of tricking investors into pouring money into what she claimed was a revolutionary testing system

Sun Pharma Advanced Research Co signs licensing pact with Biomodifying

Biomodifying will also receive a percentage of payments received for sublicenses of the licensed IP

TechInvention ties up with Korean co to bring oral cholera vaccine to India

Clinical trials of WHO pre-qualified vaccine to start soon; Unicef price is $2 per dose, private market price globally is $8-10; Initial volumes to be imported; India would need 83 mn doses a year

FM stresses on more investments in biotech, pharma R&D ahead of budget

Says India has capacity to produce Covid vaccines for itself and other countries

Gilead to acquire German biotech firm MYR for about 1.15 billion euros

The deal will also include a potential future milestone payment of up to 300 million euros

Baidu, investors in talks to raise $2 billion for biotech startup: Report

Baidu's plans come at a time of increased investment in the healthcare sector since the outbreak of the Covid-19 pandemic

Rossari Biotech to launch Rs 500 cr initial public offering on Monday

Rossari has reduced the fresh issue component from Rs 150 crore to Rs 50 crore

Nasdaq's $1.2 trillion biotech index draws Europe's Covid-19 drug hunters

Spain's Pharma Mar is looking at listing on New York's Nasdaq market, joining a flurry of biotech companies aiming to tap investors' voracious appetite for the sector

PM-led meet dwells on crop biotech, format for capital infusion in farming

Modi holds meeting on agro marketing reforms amid Covid lockdown; stresses on need to protect small farmer

Job offers revoked, IIT students find takers in IT and biotech firms

IITs have collectively written to all recruiters asking them to honour their offers

Karuna Therapeutics, little-known firm is yr's best US IPO with 420% surge

Early Karuna holders saw more than 420 per cent returns since the June IPO at $16 a share